Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CILT: CNI-free Immunosuppression After Liver Transplantation
NCT00890253Phase 2Unknown
- Start
- Jan 2010
- Primary completion
- Jan 2012
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in liver transplantation. Status: unknown.
02
Drugs
everolimus
03
Conditions
liver transplantation
Beyond the preview
Go deeper on NCT00890253.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00890253.